Form 4: Tarsus Pharmaceuticals General Counsel Bryan Wahl Reports Stock Transactions
SEC Form 4
Bryan Wahl, General Counsel of Tarsus Pharmaceuticals, reports the acquisition and disposal of company stock and Restricted Stock Units (RSUs) related to vesting and tax obligations.
Summary
- On March 15, 2024, Bryan Wahl, General Counsel of Tarsus Pharmaceuticals, acquired 12,038 shares of common stock through the settlement of vested Restricted Stock Units (RSUs).
- On March 18, 2024, Wahl sold 4,436 shares of common stock at a price of $30.6 per share.
- These sales were mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction.
- Wahl also reports ownership of 9,580 and 21,745 Restricted Stock Units (RSUs) granted in March 2022 and March 2023 respectively, which vest over four years.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by a company insider. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| March 9, 2022 | Date of RSU grant under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan (9,580 RSUs). |
| March 8, 2023 | Date of RSU grant under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan (21,745 RSUs). |
| December 31, 2023 | Date of acquisition of 1,383 shares under the Issuer's Employee Stock Purchase Plan. |
| March 15, 2024 | Acquisition of 12,038 shares through RSU settlement. |
| March 18, 2024 | Sale of 4,436 shares at $30.6 per share. |
| March 19, 2024 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.